Biomagnetics Diagnostics Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMGP research report →
About the company
Biomagnetics Diagnostics Corp. operates as a pioneering company at the forefront of advanced medical device development and biotechnology. The firm's diagnostic technologies prioritize the direct, real-time detection of viruses, toxins, or the disease itself.
- CEO
- Clayton Hardman
- IPO
- 2023
- Employees
- 2
- HQ
- Orangevale, US
Price Chart
- Market Cap
- $1.26K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.21
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -49.66%
- ROIC
- -30.40%
- Revenue
- $0 · 0.00%
- Net Income
- $-518,059 · 40.09%
- EPS
- $-0.00 · 64.00%
- Op Income
- $-381,354
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.12
- Avg Volume
- 9.52K
Get TickerSpark's AI analysis on BMGP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BMGP coverage
Recent articles, reports, and earnings notes.
No research on BMGP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMGP report →Similar companies
Peers in the same neighborhood.